Effect of pre-transplant cytoreductive therapy on the outcomes of patients with MDS or secondary AML evolving from MDS undergoing allo-HSCT: a secondary analysis of an RCT
Xue R, Dai M, Jiang E, Ou X, Huang F, Fan Z, Xu N, Yan C, Nie D, Liang X, Chen H, Ye J, Jiang L, Liu H, Jin H, Lin R, Zhang Y, Sun J, Han M, Liu Q, Wang Y, Xuan L
